PCI Pharmaceutical Consulting
|
|
- Milton Moody
- 6 years ago
- Views:
Transcription
1 PCI Pharmaceutical Consulting The Role of the QP: before & after Annex 16 Presented by: Karen Ginsbury For IFF, Denmark March 2016
2 Responsibility Authority
3 Responsibility Authority Having the duty to perform a task Being accountable for performing that task Having control over the performance of the task Without additional authorization The power or right to give orders, make decisions, and enforce obedience Within the framework of a company or organization
4 Responsibility YOUR duty to: Keep management informed Request and insist on appropriate resources Take action if authority is not granted Authority must be granted by: Owner Board of directors General manager / CEO Your boss if other than the above AND they must allow you to perform your responsibilities without interference and with appropriate resources
5 Responsibility vs Authority
6 The behaviors, beliefs and values characteristic of a particular group Culture is: Transmitted actively by defining: Mission Goals Metrics Transmitted passively and often subconsciously by behavior, body language, facial expressions and other actions
7 Better do it now Quality Quality System
8 What sort of Organization do you work in / with? active and visible support
9 Grumpy Cat What has changed? What is your most challenging issue?
10 What s Troubling Me
11 Certification by a QP and Batch Release: Annex 16 Issued October 2015 Effective 15 APRIL, 2016 Reason for update: SUPPLY CHAIN
12 Certification by a QP and Batch Release: Annex 16 Reason for update: SUPPLY CHAIN and FALSIFIED MEDICINES ACT, ICH Q8, 9, 10
13 Let s look at Annex 16 What jumps out?
14 Annex 16 Batch release pre-requisites Supplier qualification and falsified medicines directive API and excipients: Audits quality agreements CMOs: Production Packaging Other service providers
15 Annex 16 Batch release pre-requisites Validation and qualification (annex 15) in or out of scope? Computerized systems (annex 11) especially for batch release and inventory in or out of scope? Batch record review and data integrity
16 Annex 16 Batch release pre-requisites QP discretion CAPA, investigations And before any of that process mapping and risk assessment!
17 Risk Assessment for Excipients
18 What s Troubling the Inspector 2015 #1 Data integrity #2 Quality Culture (???) (attitude of most senior management??) leadership? #3 Quality Metrics #4 Drug Shortages #5 Supply chain and falsified medicines (although ties in with #1 closely)
19 GMP / GDP Inspectors Working Group
20 FDA Guidance Agenda 2015
21 What changes in last 12 months EU GMPs Part 1 Cap 3: Premises and Equipt Cap 5: Production Cap 8: Complaints, Recalls Effective: 01 Mar Mar Mar 2015 Annex 1 Annex 15 Annex 16 Annex 17 Concept paper on revision 01 Oct April 2016 Draft out
22 3 Premises and Equipment 3.6 as part of improved guidance on prevention of cross-contamination involving Cap 5
23 5 - Production
24 8 Complaints, Quality Defects and Product Recalls
25 Annex 15 Validation
26 Annex 17: Real Time Release Testing RTRT 26
27 Other US GMPs: 21CFR parts 210, 211, part 11 and part 820 FDA guidances: Draft guidance on quality metrics Quality system guidance vs ICH Q8, 9, 10 Process validation guidance Contract Manufacture
28 Other MHRA Compliance Report program and FDA on quality metrics WHO Guidances PIC/s Guidances USP, European Pharmacopoeia Pulling together the threads and staying updated
29 Hot Topics Data Integrity
30 Data Integrity does your company have a data governance policy?
31 What is Quality Meeting requirements all of them all the time and that means defining the requirements Annex 16 defines requirements for batch certification and release
32 Waivers the act of intentionally [and voluntarily] relinquishing or abandoning a known right, claim, or privilege So a planned deviation or temporary change or special release is a waiver of quality which is meeting requirements (all of them all the time)
33 Have you Heard About ISO 9001:2015?
34 Product control What is the difference Process control
35 Product vs Process Control Product Is controlled at the end of the process and you can do nothing about it you have already made the quality so you test and if it is ok release and if it is not ok you SHOULD reject but you probably get into an OOS fight Process Is controlled through understanding where the variability is and controlling critical process parameters such that all three cakes come out the same even when baked by three different students in three different ovens
36 My bread is fresh and tasty Quality control: the process of producing the product (or service) with the intent of eliminating problems that might result in defects The use of techniques and activities to achieve, sustain and improve the quality of a product
37 Where does QP Responsibility Fit? Certification and Release 37
38 CPPs and CQAs (Critical) Quality Attribute (CQA): A physical, chemical, biological or microbiological property or characteristic that should be within an appropriate limit, range, or distribution to ensure the desired product quality [= safety, efficacy, performance] (Critical) Process Parameter (CPP): A process parameter whose variability has an impact on a critical quality attribute and therefore should be monitored or controlled to ensure the process produces the desired quality 38
39 I Chart Observation I Chart Observation I Chart Observation I Chart Observation I Chart Observation I Chart Observation UCL= _ X=99.63 LCL=87.71 UCL= _ X=97.94 LCL=83.23 UCL= _ X=97.94 LCL=83.23 UCL= _ X= LCL=88.05 UCL= _ X=99.63 LCL=87.71 UCL= _ X=98.76 LCL=86.35 CPPs affect CQAs: Reliable / Predictable Known variation / Reduce Variation I N P U T S (X) Individual Value People Equipment Individual Value Measurement Individual Value Individual Value Process y = ƒ(x) Inputs to the process control variability of the Output y Individual Value OUTPUT Materials Individual Value Individual Value I Chart Observation UCL= _ X=99.95 LCL=85.72 Environment Adapted from slide by Moheb Naser, When at FDA 39 39
40 George Bernard Shaw The only man I know who behaves sensibly is my tailor - he takes my measurements anew each time he sees me. The rest go on with their old measurements and expect me to fit them
41 FDA Metrics
42 FDA Optional Metrics Related to Quality Culture and Process Capability/Performance
43 Optional metric #2
44 Optional metric #2
45 Optional metric #3
46 What Quality Data Would Be Reported
47 What Quality Data Would Be Reported
48 Measurement is the basis of the Quality Process What do we measure What could we measure What should we measure What can we measure
49 Data Collection Plans (Protocols) What data NEEDS to be collected (if all data is important then none is important) HOW should it be collected? HOW should it be analyzed? HOW should it be presented? And by who and to whom? 49
50 How many metrics BE CAREFUL if everything is important then nothing is important
51 About Measurement Measurement is the first step that leads to control and eventually to improvement If you can t measure something, you can t understand it If you can t understand it, you can t control it If you can t control it, you can t improve it. H. James Harrington
52 Measureable But Meaningful If a measurement matters at all, it is because it must have some conceivable effect on decisions and behavior If we can't identify a decision that could be affected by a proposed measurement and how it could change those decisions, then the measurement simply has no value Douglas W. Hubbard, How to Measure Anything: Finding the Value of Intangibles in Business
53 Data Collection Plans Who decides what data to collect? How do they make that decision? How do they COMMUNICATE the decision? (what are the tools) How do they educate for compliance with the data collection plan?
54 The toolbox Fabulous 14 Tools Process flow diagram Cause and effect (fishbone) Pareto chart Check sheets Location diagrams Tally count Time plot Scatter diagram Histogram Stem and Leaf Box and Whisper plot Regression analysis Control Chart Conformance chart
55 Dashboards Dashboards are reporting tools that consolidate and arrange numbers, metrics and sometimes scorecards on a single screen Usually tailored for a specific role Display metrics targeted for a single point of view or department
56 Dashboards
57 The Power of Walking the Floor Thoughts?
58 The Power of Walking the Floor You see but you do not observe Just stand and watch a production operation and ask questions about what you see Talk to operators and LISTEN to their comments You must understand the processes you are certifying
59 In Conclusion GMP isn t enough even if c Keep it Simple: Define requirements Use Risk Management to identify risks and prevent them from happening Monitor and improve in a PDCA cycle
60 In Conclusion Stay up to date Stay cool, calm and collected Ask for and make sure you get data and information in order to make informed decisions Have process maps and regularly audit or have links in the chain audited by people you trust Investigate and participate in significant deviations, changes and quality defects / complaints Refuse to be brushed aside with an it s ok Use RISK MANAGEMENT not just take risks
61 FIND ME AT: THANK YOU FOR PARTICIPATING
cgmp Update Presented by: Karen Ginsbury For IFF, Denmark November 2016
cgmp Update Presented by: Karen Ginsbury For IFF, Denmark November 2016 Trainer quiz 10 quickies Grumpy Cat Last IFF Update: March 2016 What has changed? What is your most challenging issues related to
More informationNew GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016
New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More informationQuality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017
Quality Systems Indian Pharmaceutical Alliance Advanced GMP Workshops 2017 Presented by Patrick Costello on November 2017 Principal Scientific Administrator Manufacturing & Quality Compliance An agency
More informationGMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides
FDA cgmp cgmp Guide Drugs 21 CFR 210 cgmp Guide Drugs 21 CFR 211 cgmp Guide Medical Device 21 CFR 808, 812, 820 cgmp Guide Biologics 21 CFR 600, 606, 610 Guideline List Human Drugs Guideline List Biologics
More informationPhase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017
Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/
More informationQuality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals
Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality
More informationPharmaceutical Reference Standards: Overview and Role in Global Harmonization
Matthew Borer, Ph.D., Advisor Pharmaceutical Reference Standards: Overview and Role in Global Harmonization 3rd DIA China Annual Meeting Beijing, China, 16-18 May, 2011 What is a Pharmaceutical Reference
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8
More informationRegulatory Requirements & Recent Changes, including expectations for APIs & IMPs
Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil
More informationQuality Assessment & GMP Similarities & Differences
Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences
More informationRegulatory Update. Paul Sexton. QP Forum
Regulatory Update Paul Sexton QP Forum 16 th April, 2015 Content Updates on GMP Guidance Updates on EU Legislation Draft Ph Eur monograph on WFI including RO 2 Chapter 5 - Production Paragraphs 27 to 30
More informationDrug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel
Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active
More informationEU and FDA GMP Regulations: Overview and Comparison
THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational
More informationEuropean Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009
European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities
More informationThe FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics
The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics Objectives Review Quality Systems Audit Approach and cgmp fundamentals Logistical Audit Preparation
More informationA Comprehensive Approach to Find and Remediate Data Integrity Problems
A Comprehensive Approach to Find and Remediate Data Integrity Problems June 14, 2017 Copyright 2017 QuintilesIMS. All rights reserved. What is data integrity? Whom does it apply to? Definitions matter
More informationSelf-Inspection and its potential benefits via ICH Q9 & Q10
Self-Inspection and its potential benefits via ICH Q9 & Q10 Kevin O Donnell, Ph.D. Senior Inspector & Market Compliance Manager Irish Medicines Board IMB Information Day October 23 rd, 2008 Slide 1 Topics
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7
More informationEnabling Improvement through the Product Lifecycle: Change Management within a PQS
Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,
More informationThe Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management
The Impact of Quality Culture on Quality Risk Management FDA Perspective on Quality Culture; how it Impacts Risk Management Teresa Gorecki Practice Lead Compliance Architects Agenda The WHAT Definitions
More informationDJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency
Introduction to EU Regulatory system and GMP Inspection system. The Qualified Person. DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency Any views expressed may not necessarily
More informationImpact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut
Impact of EU GMPs on Australian GMP Trevor Schoerie PharmOut Part I Basic Requirements for Medicinal Products Current TGA Version, 7 years out of date TGA are actively and publically talking about PE009-0813
More informationApplying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management
May 1-3, 2012 Javits Center New York, NY Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Control Management Arminda O. Montero Program Manager, Distribution QA Global Pharmaceutical
More informationContents. Contents (13) 1 Production (23)
1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing
More informationQS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain
QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain Presented by: Karen Ginsbury For IFF 01 March, 2017 Pharma Supply Chain Manufacturer Wholesaler Raw Material Supply Production Transport Warehouse
More informationPharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit
Pharmaceutical Good Manufacturing Practice Page 1 of 6 Why Attend A robust quality system that meets the requirements of pharmaceutical regulators is an essential element of every good pharmaceutical manufacturing
More informationTesto Expert Knowledge. The GxP Dictionary 1st edition. Definitions relating to GxP and Quality Assurance
Testo Expert Knowledge The GxP Dictionary 1st edition Definitions relating to GxP and Quality Assurance Note: Some of the information contained in this GxP Dictionary does not apply equally to all countries.
More informationFDA Quality Metrics Guidance
FDA Quality Metrics Guidance Marlène García Swider, Ph.D., CQM, CSSBB Institute of Validation Technology Quality Metrics Conference February 22 24, 2016 Coronado Island, San Diego, CA Personal Claim This
More informationTextvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf
Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern
More informationDECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW
DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW 1.0 INTRODUCTION: The purpose of this guidance is to communicate the expectation with regard to the conduct of Product Quality Review. Product Quality
More informationQuality Risk Management. of the GDP Supply Chain. Dr Cormac Dalton Inspector. Crowne Plaza Hotel, 25/2/2010. Date 22-Feb-10 Slide 1
Quality Risk Management of the GDP Supply Chain Crowne Plaza Hotel, 25/2/2010 Dr Cormac Dalton Inspector Date 22-Feb-10 Slide 1 Supply Chain Experiment Pharmaceutical excipient ordered 3 rd December 09
More informationQuality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines
Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:
More informationEU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationOverview of Regulatory Requirements for API and Formulations
Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed
More informationReferences Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.
References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which
More informationQuality Metrics: A Regulatory Perspective
Quality Metrics: A Regulatory Perspective By Tara Gooen Bizjak, MBSci CDER Office of Policy for Pharmaceutical Quality Presented By Dr. Ademola Daramola US FDA Office of International Programs Indian Pharmaceutical
More informationOverview sulla nuova guideline GDP
AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation
More informationImpacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario
Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements
More informationQuality Risk Management: Excipients
Quality Risk Management: Excipients ExcipientFest 2012 Presented by: Londa Ritchey, M.S. Director, Supplier Qualification Global Quality Operations Pfizer, Inc. Agenda Regulatory Environment Material Quality
More informationWholesaling & Distribution & the GMPs
Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the
More informationWholesaling & Distribution & the GMPs
Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the
More informationSubpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.
FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis
More informationRisk Analysis: myths, confusions and real sense
Risk Analysis: myths, confusions and real sense Dr. Alexander Fedotov, Director of Invar-project Company, Moscow, Russia fedotov@invar-project.ru www.invar-project.ru 1. What is risk analysis? 2. GMP EU
More informationFDA s Draft Guidance Request for Quality Metrics: What All Drug and Biologics Manufacturers Need to Know June 2017
FDA s Draft Guidance Request for Quality Metrics: What All Drug and Biologics Manufacturers Need to Know June 2017 Discussion Topics Quality Concepts The Journey The Guidance Details Industry Responses
More informationEU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011
Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill
More informationGxP Auditing, Remediation, and Quality System Resourcing
GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing
More informationOutsourcing - managing risks and opportunities over which you now have less control
Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance
More informationQ10 PHARMACEUTICAL QUALITY SYSTEM
Q10 PHARMACEUTICAL QUALITY SYSTEM This draft guidance, when finalized, will represent the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights
More informationConducting Supplier Audits: Ensure Validation Compliance
Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why
More informationValidation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00
Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October 2014 08:30 12:00 Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel
More informationManagement System Hilton Olympia, London 13 th February 2013
14. Building A Robust Quality Management System Hilton Olympia, London 13 th February 2013 Calcott Consulting consultant to the pharmaceutical & biotechnology industry Presenter s note Please note, the
More informationGMP Track 1 Day 2 Session 1 Vendor Assurance
GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationDeveloping an Internal Quality Auditing Program
Developing an Internal Quality Auditing Program SeerPharma Pty Lt Capsig August 2009 1 Critical Success Factors Culture of Compliance Integrate quality systems and risk management principles Well defined
More informationManaging Quality in Pharmaceutical Industry Using Six Sigma. Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA
Managing Quality in Pharmaceutical Industry Using Six Sigma Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA Outlines Pharmaceutical Manufacturing Process and Drug Product Quality. Process Excellence Approach
More informationPHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 045-1 1 July 2018 GUIDELINES ON THE FORMALISED RISK ASSESSMENT FOR ASCERTAINING THE APPROPRIATE GOOD MANUFACTURING
More informationGuidance for Industry
Guidance for Industry Q8, Q9, and Q10 Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics
More informationMaterials Management Traceability, CEPs and managing non-conforming sites
Materials Management Traceability, CEPs and managing non-conforming sites IMB Information Day, 14 th October 2010 Dr Cormac Dalton Inspector 13-Oct-10 Slide 1 Managing Supply Supply Demand Supply chain
More informationCV Mads Friis Sørensen, Elsdyrvej 18, 4623 Lille Skensved
Employment, Company and Position Jan 2007 present CV Pharmac, Founder and Senior GMP Consultant, See. Summary General consultancy for the pharmaceutical industry within the area s of Quality Assurance,
More informationMetrics in Microbiology Monitoring Practices
Metrics in Microbiology Monitoring Practices Crystal Booth, M.M. Masters of Microbiology from North Carolina State University Former Associate Director of Microbiology at Novartis Metrics in Microbiology
More informationJournal home page: RESEARCH ARTICLE
Journal home page: http://www.journalijiar.com INTERNATIONAL JOURNAL OF INNOVATIVE AND APPLIED RESEARCH RESEARCH ARTICLE QUALITY AUDIT AND GMP INSPECTION OF PHARMACEUTICAL INDUSTRY WITH REFERENCE TO USFDA;
More informationGMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB
GMP for ATMP Advanced Therapy Medicinal Products 2018 Key2Compliance AB 1 Content Background and regualtory requirements GMP Walkthrough Quality Risk Management 2018 Key2Compliance AB 2 Background and
More informationCUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)
21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software
More informationSeamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson
Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson Senior Management Consultant Agenda Introduction A state-of
More informationGood Manufacturing Practices Purpose and Principles of GMP. Tony Gould
Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines
More informationGMP The Other Side of Chemistry, Manufacturing & Controls (CMC)
Overview of USFDA Drug Regulatory Requirements Pharmaceutical Quality and Facility Inspections (GMP) Session II 19 February 2014 Casablanca, Morocco GMP The Other Side of Chemistry, Manufacturing & Controls
More informationISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua
ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND
More informationWhite paper Audits in automated production
White paper Audits in automated production data management for automation Introduction: Audits in automated production In the field of production management, audits have become an important tool for analysing
More informationHandling OOS, OOT and Unexpected Results. Karen Ginsbury PCI Pharmaceutical Consulting Israel Ltd for IFF, October 2017
Handling OOS, OOT and Unexpected Results Karen Ginsbury PCI Pharmaceutical Consulting Israel Ltd for IFF, October 2017 What is an OOS What is an OOT What is an Unusual, Questionable, Atypical Result Objective:
More informationEMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems. Jan Thomsen Warsaw, November 15 th, 2016
EMPROVE For Raw and Starting Materials & For Filtration Devices and Single Use Systems Jan Thomsen Warsaw, November 15 th, 2016 2 Content Emprove - An Introduction Emprove for Raw and Starting Materials
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General
More informationWaiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer
Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer Maklakova Olga, Quality director Kazan, 2018 Facilities 1 solid formsworkshop 1 semi-solid formsworkshop
More informationQuality Management (PQM01) Chapter 04 - Quality Control
Quality Management (PQM01) Chapter 04 - Quality Control Slide 1 Slide 2 Involves monitoring specific project results to determine if they comply with relevant quality standards, and identifying ways to
More informationHow Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)
How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S) ASQ Northeast Pharmaceutical GMP/Quality Conference January
More informationData Integrity: Points of view from a regulator
Data Integrity: Points of view from a regulator David Churchward, Expert GMP Inspector, MHRA UK Copenhagen, Denmark 23-26 November 2015 1 Introduction Important daily decisions regarding safety, efficacy
More informationUNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products
UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September
More informationHow to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York
How to Select a Microbiology Contract Testing Laboratory? Tony Cundell, Ph. D. Microbiological Consulting, LLC Scarsdale, New York June 13, 2017 IVT Microbiology Week 1 Presentation Overview Rationale
More informationGood practices in quality control in pharmaceutical industry - Overview of regulatory guidelines
Review Article Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Chagi Venkatesh*, S. B. Puranik ABSTRACT Good practices in quality control (QC) department
More informationT H E P R O P O S A L F O R T H E Y E A R
Training T H E P R O P O S A L F O R T H E Y E A R 2 0 1 9 Our GMP courses combine a convenient format with an effective, interactive learning experience. To maximize and customize your professional development.
More informationGMP Inspection Deficiencies Review of Deficiencies Observed in 2013.
GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively
More informationPrequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets
Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments
More informationExcipient GMP GDP Certification Project. Presentation to FECC Seminar Brussels 19 th March 2009 Dr Iain Moore Chair GMP Committee IPEC Europe
Excipient GMP GDP Certification Project Presentation to FECC Seminar Brussels 19 th March 2009 Dr Iain Moore Chair GMP Committee IPEC Europe Excipient GMP GDP and Certification 1. Basis for Project 2.
More informationScientific & Risk Based Compliance
www.qualitybydesign.es Scientific & Risk Based Compliance QbD Pharmaceutical Services S.L About us Mission Flexibility QbD Pharmaceutical Services S.L delivers high added-value services and specialised
More informationRegulatory Compliance Inspections at MAH Offices: Implications for Manufacturers
Regulatory Compliance Inspections at MAH Offices: Implications for Manufacturers Kevin O Donnell, Ph.D. Market Compliance Manager GMP & Market Compliance Info Day September 2012 Slide 1 What are Regulatory
More informationSupplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015
Supplier Qualification and Regulatory Compliance in International Biopharm Logistics November 19 th, Copenhagen, 2015 Pharmaceutical Quality Management Partner Selection and Qualification Outsourcing and
More informationGMP for ATMP should be a document annexed to standard GMP (a new Annex) and not a stand-alone document.
Leem comments on Commission proposal for Good Manufacturing Practice for Advanced Therapy Medicinal Products 1. General comments Line number(s) of the relevant text General comment
More informationOnline Student Guide Types of Control Charts
Online Student Guide Types of Control Charts OpusWorks 2016, All Rights Reserved 1 Table of Contents LEARNING OBJECTIVES... 4 INTRODUCTION... 4 DETECTION VS. PREVENTION... 5 CONTROL CHART UTILIZATION...
More informationSupplier Assurance Program. CBE Pty Ltd
Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.
More informationCBER Expectations Regarding Contract Manufacturing
CBER Expectations Regarding Contract Manufacturing LCDR Qiao Bobo, Ph.D. FDA/CBER/OCBQ/DMPQ CASSS CMC Strategy Forum Summer 2014 Outline 2 Types of Cooperative Manufacturing Arrangements CBER Expectations
More informationMHRA S NORMAN GRAY ON ANNEX 15 REVISION AND VALIDATION INSPECTION FINDINGS
MHRA S NORMAN GRAY ON ANNEX 15 REVISION AND VALIDATION INSPECTION FINDINGS At the ISPE/PQRI Process Validation Conference in Silver Spring, MD in early October, MHRA Senior GMP Inspector Norman Gray discussed:
More informationPROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION
1 Working document QAS/13.527/Rev.2 August 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS
More informationMASTER PLANNING FOR VALIDATION
MASTER PLANNING FOR VALIDATION By: Gamal Amer, Ph.D. Principal, Premier Compliance Services, Inc. 1 Process Validation: General Principles and Practices Guidance to industry issued by the FDA in January
More informationIncremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.
Incremental GMPs Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, 2017 1/55 Sound Science Good Development Practice Traceability R&D Tox I II III IV What You Need Here Can t be generated here
More informationComments from: 1. General comments. International Plasma Fractionation Association (IPFA) Our ref. IP
Submission of comments on Commission proposal for Good Manufacturing Practice for Advanced Therapy Medicinal Products Comments from: Name of organisation or individual International
More informationBATCH DISPOSITION BATCH DISPOSITION REGULATION. Jakarta 14 DECEMBER Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT
BATCH DISPOSITION REGULATION Jakarta 14 DECEMBER 2017 Speaker: MIMI VIRLANY SYAHPUTRI, M.Sc., S.si., APT Definition Batch disposition = product disposition = lot disposition The documented control, status
More informationStrategies to Revise Quality Policy and Quality Objectives. Eileen Cortes February 22, 2017
Strategies to Revise Quality Policy and Quality Objectives Eileen Cortes February 22, 2017 Agenda Elements of Compliance Quality Policy Outline Quality Strategy and Objectives Case Study Open Discussion
More informationCulture & the QP. Frank Hallinan Annual QP Forum 16 April 2015.
Culture & the QP. Frank Hallinan. 2015 Annual QP Forum 16 April 2015. The Big Picture: NOT about Handel, Heaney or, Hurling! What is responsibility of QP? Certify individual batches of a medicine. Assure
More information